I would like to ask.
In the quarterly report for the period ending December 2016, the company stated that:
' Alexium expects US Defense sector FR uniforms treated with AlexiflamTM to be a significant contributor to the Company’s top-line revenue model in 2017'
Does the company still expect this to be the case?
And if not,why not?what has changed/happened/not happened since the 31st of Jan.
Cheers.
Thread for shareholder questions for Dirk and Bob, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.10M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $2.087K | 298.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1210906 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 300000 | 1 |
View Market Depth
| Last trade - 15.04pm 18/07/2025 (20 minute delay) ? |
| AJX (ASX) Chart |